PUBLISHER: Grand View Research | PRODUCT CODE: 1941435
PUBLISHER: Grand View Research | PRODUCT CODE: 1941435
The global life sciences translation services market size was estimated at USD 1.70 billion in 2025 and is projected to reach USD 3.27 billion by 2033, growing at a CAGR of 8.55% from 2026 to 2033. The growing demand for clinical trials, the increasing need for Good Clinical Practice (GCP) and regulation compliance, and the globalization of the life sciences industry are some of the factors contributing to market growth.
Translation and localization are integral to the life sciences industry due to its extensive scope. This encompasses translating regulatory documents, Instructions for Use (IFUs), package labeling, marketing materials, and more. For instance, in December 2025, Sesen launched TrialS, a next-generation regulatory translation validation platform for life sciences organizations. TrialS uses AI to ensure accuracy, consistency, and regulatory alignment in global clinical and labeling submissions, addressing compliance issues traditional translation workflows miss.
"Global clinical and labeling submissions require absolute consistency. TrialS is designed to give companies regulatory confidence at scale. This launch reflects our commitment to building technology that directly solves the problems that matter most to sponsors and CROs."
Carl Yao, VP of AI Innovation and Global Business Strategy at Sesen.
Moreover, key drivers such as technological innovations in interpretation tools, increasing demand for interpreting services, and the growing need for culturally adapted medical marketing content are shaping the market. In addition, rising number of clinical trials is expected to propel market growth further. For instance, according to the National Library of Medicine, currently 563,278 studies are listed on the ClinicalTrials.gov with locations in all 51 U.S. States and in 225 countries and territories. Such factors are expected to drive the adoption of translation services in the coming years. Furthermore, advancements in translation technology, such as Neural Machine Translation (NMT) and Computer-Assisted Translation (CAT) tools powered by natural language processing (NLP), are increasingly narrowing the gap between human and automated translations, improving efficiency.
Furthermore, the rise of virtual medical practices and globalization have increased the demand for language interpreting services. Video Remote Interpretation (VRI) has become essential, providing a practical solution for multilingual patient communication and on-demand access while also providing contextual and non-verbal signs. Thus, as life sciences organizations expand into international markets, the need for culturally accurate medical marketing interpretations grows, which is expected to boost the market's growth.
Global Life Sciences Translation Services Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global life sciences translation services market report based on type, category, end use, and region: